JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB288234

APC/Cy7® Anti-CD8 alpha 抗体 [53-6.7]

APC/Cy7® Anti-CD8 alpha antibody [53-6.7]

Be the first to review this product! Submit a review

|

(2 Publications)

Rat Monoclonal CD8 alpha antibody - conjugated to APC/Cy7®. Suitable for Flow Cyt and reacts with Mouse samples. Cited in 2 publications.

別名を表示する

CD8a, Lyt-2, Lyt2, Cd8a, T-cell surface glycoprotein CD8 alpha chain, T-cell surface glycoprotein Lyt-2

2 Images
Flow Cytometry - APC/Cy7® Anti-CD8 alpha antibody [53-6.7] (AB288234)
  • Flow Cyt

Supplier Data

Flow Cytometry - APC/Cy7® Anti-CD8 alpha antibody [53-6.7] (AB288234)

Mouse BALB/c splenocytes were labelled for CD8 alpha using ab288234 at 0.1 μg/106 cells (Purple) or an isotype control (Black).

Flow Cytometry - APC/Cy7® Anti-CD8 alpha antibody [53-6.7] (AB288234)
  • Flow Cyt

Supplier Data

Flow Cytometry - APC/Cy7® Anti-CD8 alpha antibody [53-6.7] (AB288234)

Mouse BALB/c splenocytes were labelled for CD8 alpha using ab288234 at 0.1 μg/106 cells and a Rat anti-Mouse CD19-APC conjugate.

関連する標識済み抗体及び組成の異なる製品 (8)

  • 660 APC

    APC Anti-CD8 alpha antibody [53-6.7]

  • 695 APC/Cy5.5®

    APC/Cy5.5® Anti-CD8 alpha antibody [53-6.7]

  • Biotin

    Biotin Anti-CD8 alpha antibody [53-6.7]

  • 667 Cy5®

    Cy5 ® Anti-CD8 alpha antibody [53-6.7]

  • 519 FITC

    FITC Anti-CD8 alpha antibody [53-6.7]

  • 578 PE

    PE Anti-CD8 alpha antibody [53-6.7]

  • 578 PE

    PE Anti-CD8 alpha antibody [53-6.7]

  • 778 PE/Cy7®

    PE/Cy7® Anti-CD8 alpha antibody [53-6.7]

Key facts

宿主種

Rat

クローン性

Monoclonal

クローン番号

53-6.7

アイソタイプ

IgG2a

軽鎖のタイプ

kappa

標識

APC/Cy7®

励起波長/蛍光波長

Ex: 650nm, Em: 785nm

キャリアフリー

No

交差種

Mouse

アプリケーション

Flow Cyt

applications

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Mouse": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "0.1 µg for 10^6 Cells", "FlowCyt-species-notes": "<p></p>" } } }

出荷温度及び保存条件

製品の状態
Liquid
精製に関する特記事項
Purified from tissue culture supernatant.
バッファー組成
pH: 7.1 Preservative: 0.1% Sodium azide Constituents: PBS
出荷温度
Blue Ice
短期保存温度
+4°C
長期保存温度
+4°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Do Not Freeze|Store in the dark

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

CD8 alpha also known as CD8A or CD8 protein is a glycoprotein subunit expressed on the surface of cytotoxic T lymphocytes. It has a mass of approximately 32 kDa. Found on the surface cell membrane CD8 alpha functions primarily in the immune response specifically in the recognition of antigens bound to major histocompatibility complex (MHC) class I molecules. Often scientists use CD8 antibodies for detection and CD8 IHC or immunohistochemistry for localization studies.
Biological function summary

The CD8 alpha protein plays a critical role in T-cell mediated immune responses. It forms a heterodimer with the CD8 beta chain creating the CD8 alpha-beta complex that strengthens T-cell interaction with antigen-presenting cells. CD8 alpha also helps in signaling processes that activate T cells equipping them to destroy infected or malignant cells. Researchers often study CD8 alpha peptides to understand its interactions better.

Pathways

CD8 alpha is integral to the T-cell receptor signaling pathway and the cytotoxic T lymphocyte (CTL) pathway. The T-cell receptor complex which includes the CD8 molecule transmits signals that are important for T-cell activation and function. CD8 interacts with key proteins such as the T-cell receptor (TCR) and MHC class I molecules facilitating targeted responses against pathogens. These pathways highlight CD8 alpha’s role in adaptive immunity.

CD8 alpha is most prominently associated with viral infections and cancer. Conditions like HIV and some forms of leukemia show altered CD8 function highlighting the protein's role in immune surveillance. In HIV infection for instance CD8 T cells reduce in number impairing the immune response. CD8 alpha’s connection to the immune system places it alongside other immune proteins such as CD4 and MHC molecules in the context of immune dysfunction.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Integral membrane glycoprotein that plays an essential role in the immune response and serves multiple functions in responses against both external and internal offenses. In T-cells, functions primarily as a coreceptor for MHC class I molecule : peptide complex. The antigens presented by class I peptides are derived from cytosolic proteins while class II derived from extracellular proteins. Interacts simultaneously with the T-cell receptor (TCR) and the MHC class I proteins presented by antigen presenting cells (APCs). In turn, recruits the Src kinase LCK to the vicinity of the TCR-CD3 complex. LCK then initiates different intracellular signaling pathways by phosphorylating various substrates ultimately leading to lymphokine production, motility, adhesion and activation of cytotoxic T-lymphocytes (CTLs). This mechanism enables CTLs to recognize and eliminate infected cells and tumor cells. In NK-cells, the presence of CD8A homodimers at the cell surface provides a survival mechanism allowing conjugation and lysis of multiple target cells. CD8A homodimer molecules also promote the survival and differentiation of activated lymphocytes into memory CD8 T-cells.
See full target information Cd8a

文献 (2)

Recent publications for all applications. Explore the full list and refine your search

Oncology research 33:641-651 PubMed40109863

2025

Astragalus polysaccharide enhances the therapeutic efficacy of cisplatin in triple-negative breast cancer through multiple mechanisms.

Applications

Unspecified application

Species

Unspecified reactive species

L I Sun,Shichao Zhuo,Xiaoxin Li,Husheng Kong,Weiwei DU,Chong Zhou,Junxing Huang

Nature nanotechnology 17:531-540 PubMed35410368

2022

A nanovaccine for antigen self-presentation and immunosuppression reversal as a personalized cancer immunotherapy strategy.

Applications

Unspecified application

Species

Unspecified reactive species

Chao Liu,Xue Liu,Xinchu Xiang,Xin Pang,Siyuan Chen,Yunming Zhang,En Ren,Lili Zhang,Xuan Liu,Peng Lv,Xiaoyong Wang,Wenxin Luo,Ningshao Xia,Xiaoyuan Chen,Gang Liu
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com